Intelligence Β· Clinical Pipeline
Phase I Pipeline Programs
First-in-human and early clinical safety studies in Phase I.
- Programs
- 4,713
Quick answer
NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.
Top sponsors
- BRIGHT MINDS BIOSCIENCES 327 programs
- Takeda 276 programs
- Anaxis Pharma 204 programs
- Chinese Academy of 190 programs
- United Therapeutics Europe 184 programs
- Teva Pharma 154 programs
- First People's Hospital 149 programs
- Regeneron UK 126 programs
- Boehringer Ingelheim 94 programs
- Sunshine Guojian Pharmaceutical 85 programs
- Lakefront Biotherapeutics NV 62 programs
- HOFFMANN-LA ROCHE 58 programs
-
[14C]-BMS986504 Mass Balance Study in Patients with Advanced Solid Tumors with Homozygous MTAP Deletion
Bristol-Myers Squibb Australia Pty Ltd
Advanced Solid Tumors
1 trial -
[14C]-CORT113176
CORCEPT THERAPEUTICS INC
Healthy
1 trial -
[14C]-CORT125134
CORCEPT THERAPEUTICS INC
Healthy
1 trial -
[14C]-CRN00808
Crinetics Pharmaceuticals Europe GmbH
Healthy Volunteers
1 trial -
[14C]-DNL343
Denali Therapeutics
Healthy Volunteers
1 trial -
[14C]-Danicopan
Alexion Europe SAS
Healthy
1 trial -
[14C]-EDG-7500
Edgewise Therapeutics
Healthy Volunteer
1 trial -
[14C]-GSK961081 solution for IV infusion
Theravance Biopharma Ireland Umited
Pulmonary Disease, Chronic Obstructive
1 trial -
[14C]-HEC585
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy Volunteer
1 trial -
[14C]-LX4211
LEXICON PHARMACEUTICALS, INC.
Healthy
1 trial -
[14C]-Larotinib
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy Adult Male Volunteers
1 trial -
[14C]-NV-5138
SUPERNUS PHARMACEUTICALS, INC.
Healthy Volunteers
2 trials -
[14C]-PC14586
PMV Pharmaceuticals
Healthy Male Volunteers
1 trial -
[14C]-Paxalisib Capsule
KAZIA THERAPEUTICS LTD
Healthy
1 trial -
[14C]-TAK-385 Oral Solution
Takeda
Healthy Volunteers
1 trial -
[14C]-TAK-954
Takeda
Healthy Volunteers
1 trial -
[14C]-TVB-2640
Sagimet Biosciences
Healthy Volunteers
1 trial -
[14C]-benzo[a]pyrene
NORTHWEST BIOTHERAPEUTICS INC
Environmental Exposure
3 trials -
[14C]-etrumadenant
Arcus Biosciences
Healthy Participants
1 trial -
[14C]-olinciguat
Cyclerion Therapeutics
Healthy Volunteers
1 trial -
[14C]-praliciguat
Cyclerion Therapeutics
Healthy Volunteers
1 trial -
[14C]-rencofilstat 225mg
Hepion Pharmaceuticals
NASH With Fibrosis
1 trial -
[14C]-tebapivat
Agios Netherlands B.V.
Healthy Participants
1 trial -
[14C]Clifutinib
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy Adult Male
1 trial -
[14C]HSK7653
The First People's Hospital of Lianyungang
Type II Diabetes
1 trial -
[14C]IDV184001AN
Indivior Pty Ltd
Opioid Use Disorder
1 trial -
[14C]SSS17
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy Subjects (HS)
1 trial -
[14C]TGRX-326
The First People's Hospital of Lianyungang
Non Small Cell Lung Cancer
1 trial -
[177Lu]Lu-XT117
The First People's Hospital of Lianyungang
Advanced Solid Tumor
1 trial -
[18F]-Ξ±vΞ²6-BP
United Therapeutics Europe Ltd
Lung Cancer
1 trial -
[18F]APN-1607
The First People's Hospital of Lianyungang
Alzheimer Disease
1 trial -
[18F]F-AraG
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cancer
1 trial -
[18F]FP-R01-MG-F2
PLIANT THERAPEUTICS, INC.
Idiopathic Pulmonary Fibrosis
1 trial -
[18F]fluoro-PEG-folate PET/CT scan
BRIGHT MINDS BIOSCIENCES INC.
Epithelial Ovarian Cancer
1 trial -
[203Pb]VMT-Ξ±-NET
Perspective Therapeutics
Neuroendocrine Tumor Grade 2
1 trial -
[203Pb]VMT01
Perspective Therapeutics
Melanoma (Skin)
1 trial -
[212Pb] VMT-Ξ±-NET
Perspective Therapeutics
Neuroendocrine Tumors
1 trial -
[225Ac]Ac-AKY-1189 (therapeutic)
Aktis Oncology
Urothelial Carcinoma Bladder
1 trial -
[225Ac]Ac-AKY-2519 (therapeutic)
Aktis Oncology
Castration Resistant Metastatic Prostate Cancer
1 trial -
[68Ga]Ga-PentixaFor
CERO THERAPEUTICS HOLDINGS, INC.
triple-negative breast cancer
1 trial -
[68Ga]Ga-Sa-DABI-4
The First People's Hospital of Lianyungang
Stimulator of Interferon Gene
1 trial -
[68Ga]MLN6907
Takeda
Imaging of Solid Gastrointestinal Tumors
1 trial -
[F18]-ASEM (3-(1,4-diazabicyclo[3.2.2]nonan-4-yl)-6-[18F]fluorodibenzo[b,d]thiophene 5,5-dioxide)
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Use Disorder
1 trial -
[^14C]-alisertib
Takeda
Advanced Solid Tumors
1 trial -
a 60 mg dose of the hydrocodone bitartrate extended-release tablet administered as either two 30-mg tablets (Treatment A) or one 60-mg tablet (Treatment B).
Teva Pharma GmbH
Pain
1 trial -
acetylsalicylic acid
United Therapeutics Europe Ltd
Precancerous Condition
1 trial -
acupuncture
United Therapeutics Europe Ltd
Migraine Headaches
1 trial -
administration of UI018
United Therapeutics Europe Ltd
Hyperlipemia, Mixed
1 trial
Frequently asked questions
How many Phase I pipeline programs are in the directory?
4,713 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.
Data attribution: Data sources Β· All pipeline programs